Esperovax

Esperovax is a biotechnology company focused on developing innovative oral biologic medicines using a proprietary platform. The company specializes in a novel vaccine technology that delivers targeted mRNA therapies directly to patients, aiming to produce effective therapeutic outcomes by engaging the body's immune system. By utilizing molecular-based technology, Esperovax's approach offers a convenient and painless alternative to traditional needle-based delivery methods, thereby enhancing access to critical treatments. This unique platform positions Esperovax to significantly improve patient experience and expand the reach of life-saving medications.